StockData
Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc. (VYGR) stock

VYGRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3058% below fair value
$1.52−0.11 (-6.75%)

Close on Nov 17, 2026Market cap $93.66MP/E –Yield –

Voyager Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Voyager Therapeutics's price to book ratio was 0.7× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.6× to 5.0×, with a median of 1.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×−0.3
2025Dec 31, 20251.0×+0.1
2024Dec 31, 20240.9×−1.2
2023Dec 29, 20232.1×−0.8
2022Dec 30, 20222.9×+1.8
2021Dec 31, 20211.2×−0.4
2020Dec 31, 20201.6×−3.1
2019Dec 31, 20194.8×+0.1
2018Dec 31, 20184.6×−0.5
2017Dec 29, 20175.1×+2.9
2016Dec 30, 20162.2×–

More Voyager Therapeutics figures

See a number that looks wrong?